Categories: Entertainment

Not sure how to give wishes for the Year of the Horse? Let’s hear from CGs in Guangzhou

GUANGZHOU, China, Feb. 20, 2026 /PRNewswire/ — A news report from South:

- Advertisement -

As we gallop into the Year of the Horse, Guangdong is poised to strengthen international cooperation and deliver even greater benefits through win-win partnerships.

- Advertisement -

To celebrate this auspicious Chinese New Year, Consuls General in Guangzhou joined South to extend their horse-themed blessings to the people of Guangdong, sharing their visions of friendship and collaboration in the year ahead.

- Advertisement -

How will the bond between Guangdong and the world continue to thrive in this new chapter? What exciting opportunities are waiting just around the corner? Click the video to gallop into the Year of the Horse with us.

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/not-sure-how-to-give-wishes-for-the-year-of-the-horse-lets-hear-from-cgs-in-guangzhou-302693305.html

- Advertisement -
PRNW Agency

Recent Posts

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20,…

44 minutes ago

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

February 20, 2026 17:16 ET  | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE…

44 minutes ago

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

February 20, 2026 16:49 ET  | Source: Bel Fuse Inc. WEST ORANGE, N.J., Feb. 20,…

44 minutes ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…

2 hours ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a…

2 hours ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or…

2 hours ago